# Ryan Specialty Holdings, Inc.: financial statements, quarterly

RYAN · NYSE · CIK 1849253 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ryan.md) · [Financials](/companies/ryan/financials.md) · [Filings](/companies/ryan/filings.md) · [Insiders](/companies/ryan/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ryan/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [487](/filings/0001628280-24-044413.md) | [519 d](/filings/0001849253-26-000006.md) | [538](/filings/0001628280-25-021664.md) | [680](/filings/0001628280-25-037141.md) | [588](/filings/0001849253-25-000016.md) | [649 d](/filings/0001849253-26-000006.md) | [676](/filings/0001849253-26-000026.md) | [841](/filings/0001849253-26-000036.md) | [740](/filings/0001849253-25-000016.md) | [738 d](/filings/0001849253-26-000006.md) | [783](/filings/0001849253-26-000026.md) | [903](/filings/0001849253-26-000036.md) |
| Operating income | $m | [69.8](/filings/0001628280-24-044413.md) | [96.3 d](/filings/0001849253-26-000006.md) | [72.6](/filings/0001628280-25-021664.md) | [164](/filings/0001628280-25-037141.md) | [81.5](/filings/0001849253-25-000016.md) | [109 d](/filings/0001849253-26-000006.md) | [100](/filings/0001849253-26-000026.md) | [191](/filings/0001849253-26-000036.md) | [111](/filings/0001849253-25-000016.md) | [91.6 d](/filings/0001849253-26-000006.md) | [94.6](/filings/0001849253-26-000026.md) | [180](/filings/0001849253-26-000036.md) |
| Interest expense | $m | [31.5](/filings/0000950170-23-058503.md) | [29.7 d](/filings/0000950170-24-021657.md) | [29.4](/filings/0000950170-24-052483.md) | [31.1](/filings/0000950170-24-089593.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [24.8](/filings/0001628280-24-044413.md) | [0.7 d](/filings/0001849253-26-000006.md) | [6.4](/filings/0001628280-25-021664.md) | [18.7](/filings/0001628280-25-037141.md) | [(9.0)](/filings/0001849253-25-000016.md) | [26.5 d](/filings/0001849253-26-000006.md) | [55.4](/filings/0001849253-26-000026.md) | [13.0](/filings/0001849253-26-000036.md) | [(2.8)](/filings/0001849253-25-000016.md) | [13.4 d](/filings/0001849253-26-000006.md) | [6.5](/filings/0001849253-26-000026.md) | [22.4](/filings/0001849253-26-000036.md) |
| Net income | $m | [(5.0)](/filings/0001628280-24-044413.md) | [22.8 d](/filings/0001849253-26-000006.md) | [16.5](/filings/0001628280-25-021664.md) | [46.8](/filings/0001628280-25-037141.md) | [17.6](/filings/0001849253-25-000016.md) | [13.8 d](/filings/0001849253-26-000006.md) | [(27.6)](/filings/0001849253-26-000026.md) | [52.0](/filings/0001849253-26-000036.md) | [31.1](/filings/0001849253-25-000016.md) | [8.0 d](/filings/0001849253-26-000006.md) | [17.6](/filings/0001849253-26-000026.md) | [42.3](/filings/0001849253-26-000036.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.8](/filings/0001628280-24-044413.md) | [0.8](/filings/0001849253-26-000006.md) | [0.7](/filings/0001628280-25-021664.md) | [0.6](/filings/0001628280-25-037141.md) | [0.2](/filings/0001849253-25-000016.md) | [0.5](/filings/0001849253-26-000006.md) | [0.2](/filings/0001849253-26-000026.md) | [0.2](/filings/0001849253-26-000036.md) | [0.2](/filings/0001849253-25-000016.md) | [0.2](/filings/0001849253-26-000036.md) | [0.2](/filings/0001849253-26-000026.md) | [0.1](/filings/0001849253-26-000036.md) |
| Current assets | $bn | [3.6](/filings/0000950170-23-058503.md) | [4.3](/filings/0001628280-25-006973.md) | [4.2](/filings/0000950170-24-052483.md) | [5.1](/filings/0000950170-24-089593.md) | [4.0](/filings/0001628280-24-044413.md) | [4.8](/filings/0001849253-26-000006.md) | [4.6](/filings/0001628280-25-021664.md) | [5.3](/filings/0001628280-25-037141.md) | [4.4](/filings/0001849253-25-000016.md) | [5.1](/filings/0001849253-26-000036.md) | [5.6](/filings/0001849253-26-000026.md) | [6.6](/filings/0001849253-26-000036.md) |
| Total assets | $bn | [6.4](/filings/0000950170-23-058503.md) | [7.2](/filings/0001628280-25-006973.md) | [7.1](/filings/0000950170-24-052483.md) | [8.3](/filings/0000950170-24-089593.md) | [8.5](/filings/0001628280-24-044413.md) | [9.6](/filings/0001849253-26-000006.md) | [9.9](/filings/0001628280-25-021664.md) | [10.6](/filings/0001628280-25-037141.md) | [9.9](/filings/0001849253-25-000016.md) | [10.6](/filings/0001849253-26-000036.md) | [11.0](/filings/0001849253-26-000026.md) | [12.0](/filings/0001849253-26-000036.md) |
| Current liabilities | $bn | [3.0](/filings/0000950170-23-058503.md) | [3.7](/filings/0001628280-25-006973.md) | [3.7](/filings/0000950170-24-052483.md) | [4.7](/filings/0000950170-24-089593.md) | [4.0](/filings/0001628280-24-044413.md) | [4.5](/filings/0001849253-26-000006.md) | [4.4](/filings/0001628280-25-021664.md) | [5.2](/filings/0001628280-25-037141.md) | [4.5](/filings/0001849253-25-000016.md) | [5.2](/filings/0001849253-26-000036.md) | [5.5](/filings/0001849253-26-000026.md) | [6.7](/filings/0001849253-26-000036.md) |
| Total liabilities | $bn | [5.5](/filings/0000950170-23-058503.md) | [6.3](/filings/0001628280-25-006973.md) | [6.1](/filings/0000950170-24-052483.md) | [7.2](/filings/0000950170-24-089593.md) | [7.4](/filings/0001628280-24-044413.md) | [8.6](/filings/0001849253-26-000006.md) | [8.8](/filings/0001628280-25-021664.md) | [9.4](/filings/0001628280-25-037141.md) | [8.6](/filings/0001849253-25-000016.md) | [9.3](/filings/0001849253-26-000036.md) | [9.8](/filings/0001849253-26-000026.md) | [11.0](/filings/0001849253-26-000036.md) |
| Long-term debt | $bn | [1.9](/filings/0000950170-23-058503.md) | [1.9](/filings/0001628280-25-006973.md) | [1.9](/filings/0000950170-24-052483.md) | [1.9](/filings/0000950170-24-089593.md) | [2.6](/filings/0001628280-24-044413.md) | [3.2](/filings/0001849253-26-000006.md) | [3.7](/filings/0001628280-25-021664.md) | [3.4](/filings/0001628280-25-037141.md) | [3.3](/filings/0001849253-25-000016.md) | [3.3](/filings/0001849253-26-000036.md) | [3.5](/filings/0001849253-26-000026.md) | [3.6](/filings/0001849253-26-000036.md) |
| Current portion of debt | $bn | [0.0](/filings/0000950170-23-058503.md) | [0.0](/filings/0001628280-25-006973.md) | [0.0](/filings/0000950170-24-052483.md) | [0.0](/filings/0000950170-24-089593.md) | [0.0](/filings/0001628280-24-044413.md) | [0.1](/filings/0001849253-26-000006.md) | [0.0](/filings/0001628280-25-021664.md) | [0.1](/filings/0001628280-25-037141.md) | [0.0](/filings/0001849253-25-000016.md) | [0.1](/filings/0001849253-26-000036.md) | [0.0](/filings/0001849253-26-000026.md) | [0.1](/filings/0001849253-26-000036.md) |
| Shareholders' equity | $bn | [0.5](/filings/0000950170-23-058503.md) | [0.6](/filings/0001628280-25-006973.md) | [0.6](/filings/0000950170-24-052483.md) | [0.6](/filings/0000950170-24-089593.md) | [0.6](/filings/0001628280-24-044413.md) | [0.6](/filings/0001849253-26-000006.md) | [0.5](/filings/0001628280-25-021664.md) | [0.6](/filings/0001628280-25-037141.md) | [0.6](/filings/0001849253-25-000016.md) | [0.6](/filings/0001849253-26-000036.md) | [0.6](/filings/0001849253-26-000026.md) | [0.5](/filings/0001849253-26-000036.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [105 d](/filings/0001628280-24-044413.md) | [227 d](/filings/0001849253-26-000006.md) | [(117)](/filings/0001628280-25-021664.md) | [271 d](/filings/0001628280-25-037141.md) | [101 d](/filings/0001849253-25-000016.md) | [260 d](/filings/0001849253-26-000006.md) | [(143)](/filings/0001849253-26-000026.md) | [354 d](/filings/0001849253-26-000036.md) | [170 d](/filings/0001849253-25-000016.md) | [263 d](/filings/0001849253-26-000006.md) | [(167)](/filings/0001849253-26-000026.md) | [293 d](/filings/0001849253-26-000036.md) |
| Capital expenditure | $m | not reported | not reported | [0.0](/filings/0001628280-25-021664.md) | [0.0 d](/filings/0001628280-25-037141.md) | [0.0 d](/filings/0001849253-25-000016.md) | [0.0 d](/filings/0001849253-26-000006.md) | [0.7](/filings/0001849253-26-000026.md) | [0.0 d](/filings/0001849253-26-000036.md) | [2.4 d](/filings/0001849253-25-000016.md) | [0.0 d](/filings/0001849253-26-000006.md) | [0.0](/filings/0001849253-26-000026.md) | [1.6 d](/filings/0001849253-26-000036.md) |
| Dividends paid | $m | [0.0 d](/filings/0001628280-24-044413.md) | [0.0 d](/filings/0001849253-26-000006.md) | [40.0](/filings/0001628280-25-021664.md) | [13.0 d](/filings/0001628280-25-037141.md) | [13.5 d](/filings/0001849253-25-000016.md) | [13.7 d](/filings/0001849253-26-000006.md) | [15.1](/filings/0001849253-26-000026.md) | [15.4 d](/filings/0001849253-26-000036.md) | [16.3 d](/filings/0001849253-25-000016.md) | [15.5 d](/filings/0001849253-26-000006.md) | [16.8](/filings/0001849253-26-000026.md) | [16.9 d](/filings/0001849253-26-000036.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001849253-26-000026.md) | [0.0 d](/filings/0001849253-26-000036.md) | not reported | not reported | [40.0](/filings/0001849253-26-000026.md) | [260 d](/filings/0001849253-26-000036.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 109,903,867 at 2021-09-01, from the cover of the [10-Q filed 2021-09-02](/filings/0001193125-21-264503.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.